EPIX Essa Pharma Inc.

ESSA Pharma Inc is a development stage pharmaceutical company. The Company is engaged in developing proprietary small molecule compound named EPI-506 as a treatment for prostate cancer.

$2.82
As of 07/01/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Canada
IPO date:  03/13/2015
Outstanding shares:  32,064,411
Average volume:  191,227
Market cap:   $111,584,150
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.78
PS ratio:   0.00
Return on equity:   -20.85%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy